Visit COVID-19 resources

[Skip to Content]

IRay therapy as an adjuvant therapy in newly diagnosed patients with neovascular age-related macular degeneration – (IRay therapy as an adjuvant therapy in newly diagnosed patients with neovascular age-related macular degeneration, Published online: 2018-04-17; | doi:10.1038/s41433-018-0080-9)

17 April 2018

This news item is available to RCOphth members only, please log in below to access.

Members Login